Login to Your Account



Erytech Pharma Goes Public in France with $21M IPO

By Nuala Moran
Staff Writer

Wednesday, May 15, 2013
LONDON – Shares in Erytech Pharma SA began trading in Paris last week following an initial public offering (IPO) that exceeded the €15 million (US$19.5 million) target, raising €16.7 million.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription